# Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

> **NCT06248099** · PHASE1 · UNKNOWN · sponsor: **Bio-innova Co., Ltd** · enrollment: 46 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Nebivolol-Test product
- **DRUG:** Nebivolol-Reference product

## Key facts

- **NCT ID:** NCT06248099
- **Lead sponsor:** Bio-innova Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-07-09
- **Primary completion:** 2024-08-17
- **Final completion:** 2024-09-14
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06248099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06248099, "Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06248099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*